Vizamyl Solution
Product Images NDC 17156-067

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Vizamyl (NDC 17156-067). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ge Healthcare Inc. (medi-physics, Inc. Dba Ge Healthcare), these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Vizamyl 01)

An illustration showing comparative brain scans labeled 'Negative scan' and 'Positive scan' for Flutemetamol F-18 imaging. The scans display cross-sectional views of the brain with color-coded regions indicating tracer uptake, using a color scale from blue (low) to red (high). Anatomical regions labeled include 'f,' 's,' and 'lt,' with red target lines centered on key areas. The image highlights differences in tracer distribution between negative and positive diagnostic scans.*

FDA Label Image

Figure 2 (Vizamyl 02)

A PET scan image comparing negative and positive scans of brain activity using Flutemetamol F-18, the active ingredient in Vizamyl. The colored heat map, ranging from blue (low) to red (high), highlights brain regions labeled as pc and cc. The negative scan shows lower activity levels, while the positive scan reveals increased activity indicated by warmer colors.*

FDA Label Image

Figure 3 (Vizamyl 03)

A comparative brain scan image showing two PET scan results labeled 'Negative scan' and 'Positive scan' for Vizamyl (Flutemetamol F-18). The scans highlight differential radiotracer uptake in brain regions indicated as 'pc' (posterior cingulate) and 'ip' (inferior parietal). A color scale bar on the right represents intensity ranging from 0.0 to 1.0.*

FDA Label Image

Chemical Structure (Vizamyl 04)

Chemical structure diagram of Flutemetamol F-18, the active ingredient in Vizamyl 4.05 mCi/mL intravenous solution by GE Healthcare Inc. The structure shows labeled fluorine-18 isotope on a phenyl ring and several connected aromatic and heterocyclic rings.*

FDA Label Image

Principal Display Panel (Shield Label)

Label for Vizamyl (Flutemetamol F 18 Injection) solution, 4.05 mCi/mL, in a 30 mL multiple-dose vial. The label indicates it is sterile, non-pyrogenic, and for intravenous diagnostic use only. It includes storage instructions, radioactive material caution, manufacturer details (Cardinal Health for GE Healthcare), and placeholders for batch number, date, and expiration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.